Advancing Nanomedicines from Formulation to Scale-Up to Clinical Supply.
At Phosphorex, we offer a range of innovative solutions for the delivery of nucleic acids, facilitating cellular entry and endosome escape including liposomes, lipid nanoparticles, and cationic polymers.
Our team accelerates the development of nanomedicines by fabricating nanoparticles, modifying their surface for different targeting needs, scaling up to support preclinical and IND-enabling studies and developing GMP processes.
Our team of experts offer tailored solutions to optimize a drug's release and long-acting profile to achieve the desired therapeutic effect, reduce side effects and enhance patient compliance.
Press Announcement: Phosphorex and NOF Corporation launches Innovation and Training Center in Hopkington, MA....
Phosphorex leverages its expertise in particle-based formulations to address the challenges associated with therapeutic agent delivery. We understand the need for specific tissue or cell targeting to maximize therapeutic effects, especially in cases where current modalities lack such capabilities. Read more
We have worked with numerous advanced drug payload types designed to revolutionize delivery in various therapeutic areas. We support tailored solutions to address specific application needs in the following modalities
Our experience spans a range of payloads suited to a variety of applications and research needs. Our team is committed to providing the highest quality standard of services to our clients with efficacy, stability, and safety as our top priority.
We have been working with Phosphorex for about 3 years developing particulate delivery systems for both small molecule and gene based therapeutics to treat retinal degeneration. We are a small company, so in addition to the very challenging technical issues, there were resource constraints and aggressive timelines. Despite those challenges Phosphorex delivered for us...and in a very collegial way....awesome group of folks to work with.
Our specialized team is dedicated to supporting innovative drug delivery solutions that enhance the efficacy and safety of a wide range of therapeutics. We are committed to advancing the field of drug delivery, ensuring optimal outcomes for patients and maximizing the potential of your therapies.
With 18 years of experience for particle-based formulation and development, we are committed to ensuring our client's success every step of the way, from proof of concept to clinical studies. We are excited to offer cGMP capabilities in 2024.
Phosphorex is a CDMO specializing in innovative and proven particle-based drug delivery solutions. Our two-decade of experience, fortified with skilled and dedicated employees (scientists), yields trusted and collaborative Pharma & Biotech partnerships.
Our leadership team is comprised of experienced and dedicated individuals who are committed to ensuring the success of our organization.
We are excited that you're considering joining our team. Our employees are our greatest assets, and we are committed to offering a supportive and collaborative work environment.